Mode
Text Size
Log in / Sign up

Virome and mycobiome roles in female reproductive tract health are increasingly recognized as potential ecosystem modulators.

Virome and mycobiome roles in female reproductive tract health are increasingly recognized as potent…
Photo by Nathan Rimoux / Unsplash
Key Takeaway
Consider emerging virome and mycobiome roles in FRT health as potential ecosystem modulators requiring further investigation.

This systematic scoping review investigated the impact of the virome and mycobiome on female reproductive tract (FRT) health, contrasting these findings with the traditional bacteriocentric paradigm that focuses primarily on bacteria, particularly Lactobacillus species. The review did not report a specific sample size, study phase, or setting for the included evidence. The primary outcome assessed was the role of these non-bacterial elements in FRT health.

The analysis proposed that bacteriophage function acts as a community modulator. Specifically, lytic cycles were suggested to maintain bacterial diversity, whereas lysogenic cycles might contribute to stabilizing pathogenic biofilms in dysbiosis conditions like bacterial vaginosis by introducing virulence genes. Additionally, the review noted that Candida species can transition from harmless commensals to pathogens when the protective bacterial balance is disturbed. No absolute numbers, effect sizes, p-values, or confidence intervals were reported for these outcomes.

Safety and tolerability data, including adverse events and discontinuations, were not reported in the review. The authors highlighted that future therapeutic strategies should move beyond a one-bug, one-drug approach toward ecosystem restoration. Potential targeted methods mentioned include phage therapy or vaginal microbiota transplantation. However, the review did not provide specific data to support the efficacy or safety of these interventions at this stage.

Key limitations include the lack of reported absolute numbers, effect sizes, and statistical measures for the proposed mechanisms. The evidence is observational in nature, and causality was not reported. Consequently, the practice relevance is framed as a conceptual shift rather than an immediate change in standard of care based on robust quantitative evidence.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BackgroundTraditional research on the female reproductive tract (FRT) microbiome has focused on the dominance of bacteria, particularly Lactobacillus, as a marker of health. This bacteriocentric paradigm, however, cannot fully explain clinical enigmas like the high recurrence of bacterial vaginosis (BV) or the persistence of HPV infection. This review introduces a new pan-microbiome framework that highlights the overlooked roles of the virome and mycobiome as the ecosystem’s neglected components.MethodsWe conducted a systematic scoping review following the PRISMA-ScR guidelines. We searched PubMed, Embase, and Web of Science databases for studies published up to October 2025. Inclusion criteria focused on original research and metagenomic studies examining the female reproductive tract (FRT) virome, mycobiome, and bacteriome, specifically their interactions and clinical associations with bacterial vaginosis (BV) and HPV persistence. Data were extracted and synthesized to evaluate the pan-microbiome framework.ResultsThe virome and mycobiome, despite their low biomass, are increasingly recognized as potential ecosystem modulators. Bacteriophages, for instance, are proposed to act as community “modulators,” either through lytic cycles that maintain bacterial diversity or lysogenic cycles that may contribute to stabilizing pathogenic biofilms in dysbiosis like BV by introducing virulence genes. Similarly, fungi like Candida can transition from harmless commensals to pathogens when the protective bacterial balance is disturbed.ConclusionFRT health is an emergent property of the complex interactions among bacteria, viruses, and fungi. A comprehensive understanding requires a pan-microbiome perspective. Future therapeutic strategies should move beyond a “one-bug, one-drug” approach toward “ecosystem restoration,” using targeted methods like phage therapy or vaginal microbiota transplantation to attempt to restore the balance of the entire microbial community.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.